Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders

Samad Fereidooni; Banafsheh Gharaei; Behrooz Birashk; Ali Sahraeian; Seyed Mohammad Davood Hoseini

doi:10.5455/jmood.20140913061428

2024, Vol: 14, Issue: 3

14 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

COPYRIGHT FORM
_Title_Page_Obligatory_(v2r)_

« Previous Article

Original Research
Online Published: 30 Sep 2015

PBS. 2015; 5(3): 104-12

doi: 10.5455/jmood.20140913061428

Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini.

Abstract
Objective: It is important to consider history of dealing with depression as it evolved from pure behavioral approaches that predate behavioral activation. Current behavioral activation adds an idiographic and functional approaches, which explores clients needs, goals and environmental contingencies that support depressive behaviors and moods. The aim of this study is to evaluate efficacy of Group Behavioral Activation Treatment (GBAT) as a supplemental treatment to pharmacotherapy in inpatients suffering from depressive disorders.
Methods: This is a clinical trial. We included 24 patients with depressive disorders (according to SCID-I), who were admitted to Shiraz Psychiatric Hospital in summer 2010. They were randomly divided into three groups: intervention, control, and placebo. All three groups prescribed their usual pharmacological treatment. Additionally, first group was treated with GBAT. In order to control the efficacy of therapists attention, third group watched video-movie as well. All participants completed Beck Depression Inventory-II (BDI-II) and Behavioral Activation for Depression Scale (BADS).
Results: According to the results of the analysis of variance for repeated measures: all 3 groups showed same decrease in post and 2 mounts follow-up in BDI-II, however there was no significant difference among groups. Nevertheless, based on the results of analysis for BDI-II, it is indicated that behavioral activation therapy has been effective in decreasing depression of patients (F=11.27; p=0.001). Results indicated that based on the analysis of BADS, patients depression has significantly decreased (F=105.97; p=0.001).
Conclusions: Our research findings indicate that using the GBAT as a supplemental treatment for depressed inpatients can increase the effectiveness of medication therapy. Small sample size and cautions in the generalization of the present findings to be noted.

Key words: Group Behavioral Activation Treatment (GBAT), pharmacotherapy, depressive disorders, inpatients, supplemental treatment.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Samad Fereidooni Articles by Banafsheh Gharaei Articles by Behrooz Birashk Articles by Ali Sahraeian Articles by Seyed Mohammad Davood Hoseini
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. 2015; 5(3): 104-12. doi:10.5455/jmood.20140913061428

Web Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. https://www.pbsciences.org/?mno=162353 [Access: September 13, 2024]. doi:10.5455/jmood.20140913061428

AMA (American Medical Association) Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. 2015; 5(3): 104-12. doi:10.5455/jmood.20140913061428

Vancouver/ICMJE Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. (2015), [cited September 13, 2024]; 5(3): 104-12. doi:10.5455/jmood.20140913061428

Harvard Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini (2015) Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS, 5 (3), 104-12. doi:10.5455/jmood.20140913061428

Turabian Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. 2015. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. Psychiatry and Behavioral Sciences, 5 (3), 104-12. doi:10.5455/jmood.20140913061428

Chicago Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. "Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders." Psychiatry and Behavioral Sciences 5 (2015), 104-12. doi:10.5455/jmood.20140913061428

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini (2015) Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. Psychiatry and Behavioral Sciences, 5 (3), 104-12. doi:10.5455/jmood.20140913061428

Author Login Reviewer Login

About Psychiatry and Behavioral Sciences

Contact Information

How to cite this article